Kinaseprofiling voor therapieselectie bij uitbehandelde kankerpatiënten.
Recruiting
- Conditions
- Gemetastaseerde solide tumorenVergevorderde (uitgezaaide of inoperabele) kankerAdvanced solid tumorsMetastasized or inoperable cancer
- Registration Number
- NL-OMON22647
- Lead Sponsor
- Prof. dr. H.M.W. Verheul, M.D., Ph.D.Head Department of Medical OncologyVU University Medical CenterDe Boelelaan 11171081 HV AmsterdamThe NetherlandsTel: +31 (0)20-4444321/300Fax: + 31 (0)20-4444079Email: h.verheul@vumc.nl
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 43
Inclusion Criteria
1. Patients presenting with an advanced (unresectable and/or metastatic) solid malignancy for whom no standard treatment is available;
2. Patients should have received at least one prior standard medical treatment regimen for their advanced disease;
Exclusion Criteria
1. History of cardiac disease:
A. Congestive heart failure >NYHA class 2;
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method